Neuphoria Therapeutics (NEUP) Depreciation & Amortization (CF) (2023 - 2026)
Neuphoria Therapeutics (NEUP) posted Depreciation & Amortization (CF) of $165,679 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $165,625 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics' Depreciation & Amortization (CF) came in at $662,955, unchanged from FY2025.
- Annual Depreciation & Amortization (CF) shows a three-year compound annual growth rate of 0.0% (FY2023 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Depreciation & Amortization (CF) was $662,890 in FY2025 (unchanged), $662,991 in FY2024 (unchanged) and $663,192 in FY2023.
- Quarterly Depreciation & Amortization (CF) has run from a low of $165,431 in fiscal Q3 2025 to a high of $166,121 in fiscal Q2 2025 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) increased in two of the last eight quarters, with an average year-over-year change of 0.0%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior fiscal quarters was $165,695 (Q3 2026), $165,789 (Q2 2026) and $165,792 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 165,679.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165,679.00 |
| Mar 31, 2026 | 165,695.00 |
| Dec 31, 2025 | 165,789.00 |
| Sep 30, 2025 | 165,792.00 |
| Jun 30, 2025 | 165,625.00 |
| Mar 31, 2025 | 165,431.00 |
| Dec 31, 2024 | 166,121.00 |
| Sep 30, 2024 | 165,713.00 |
| Jun 30, 2024 | 165,685.00 |
| Mar 31, 2024 | 165,703.00 |
| Dec 31, 2023 | 165,694.00 |
| Sep 30, 2023 | 165,909.00 |
API Access
Neuphoria Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();